Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Vir Biotechnology, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 215
- +8 vs. Q1 2024
- Shares held
- 88.0M
- −761.9K (−0.9%) vs. Q1 2024
- Total value
- $783.1M
- −$116.6M (−13.0%) vs. Q1 2024
- New holders
- 34
- 75 more added
- Sold out
- 26
- 72 more reduced
3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 237 | $1.49B |
| Q1 2026 | 252 | $1.25B |
| Q4 2025 | 218 | $696.5M |
| Q3 2025 | 213 | $610.8M |
| Q2 2025 | 213 | $558.5M |
| Q1 2025 | 234 | $604.5M |
| Q4 2024 | 208 | $652.0M |
| Q3 2024 | 197 | $656.3M |
| Q2 2024 | 215 | $783.1M |
| Q1 2024 | 210 | $901.0M |
| Q4 2023 | 207 | $887.2M |
| Q3 2023 | 215 | $827.4M |
| Q2 2023 | 227 | $2.23B |
| Q1 2023 | 234 | $2.06B |
| Q4 2022 | 225 | $2.18B |
| Q3 2022 | 221 | $1.68B |
| Q2 2022 | 214 | $2.20B |
| Q1 2022 | 204 | $2.09B |
| Q4 2021 | 210 | $3.25B |
| Q3 2021 | 175 | $3.24B |
| Q2 2021 | 166 | $3.64B |
| Q1 2021 | 157 | $3.87B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 922,554 | $8.21M | 0.01% | +276,300+42.8% | Added |
| Charles Schwab Investment Management Inc | 998,189 | $8.88M | 0.00% | +168,878+20.4% | Added |
| Voloridge Investment Management, LLC | 1,224,898 | $10.9M | 0.04% | +521,370+74.1% | Added |
| Millennium Management LLC | 1,248,131 | $11.1M | 0.01% | +606,804+94.6% | Added |
| JPMorgan Chase & Co | 1,255,298 | $11.2M | 0.00% | +792,051+171.0% | Added |
| Renaissance Technologies LLC | 1,329,700 | $11.8M | 0.02% | −26,400−1.9% | Reduced |
| Bill & Melinda Gates Foundation | 1,559,142 | $13.9M | 34.50% | 00.0% | Unchanged |
| Morgan Stanley | 2,123,212 | $18.9M | 0.00% | −216,048−9.2% | Reduced |
| Geode Capital Management, LLC | 2,183,628 | $19.4M | 0.00% | +234,439+12.0% | Added |
| OrbiMed Advisors LLC | 2,320,102 | $20.6M | 0.44% | +1,680,102+262.5% | Added |
| Baillie Gifford & Co | 3,921,242 | $34.9M | 0.03% | −25,823−0.7% | Reduced |
| State Street Corp | 5,094,888 | $45.3M | 0.00% | −1,972,733−27.9% | Reduced |
| Vanguard Group Inc | 12,849,217 | $114.4M | 0.00% | +473,862+3.8% | Added |
| BlackRock Inc. | 16,434,122 | $146.3M | 0.00% | −129,490−0.8% | Reduced |
| SB Investment Advisers (UK) Ltd | 16,684,041 | $148.5M | 1.37% | 00.0% | Unchanged |
| Capital International Investors | 0 | $0 | 0.00% | −258,400−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −172,656−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −101,479−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −95,242−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −92,153−100.0% | Sold out |
| Texas Permanent School Fund | 0 | $0 | 0.00% | −74,977−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −45,266−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −35,766−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −33,607−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −30,734−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −25,600−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −20,761−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −13,336−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −11,714−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −11,642−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,971−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −10,925−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −8,287−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,869−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −3,794−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| Mine & Arao Wealth Creation & Management, LLC. | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | 0 | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Oracle Alpha Inc. | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |